Answers are grounded in this paper and cite their sources.
Benchmark reveals key performance drivers in cell type expression deconvolution methods, suggesting new metrics for accuracy.
Deconvolution of bulk transcriptomic data unlocks rich, cell type specific insights from complex tissue samples. While cell type fraction deconvolution has been extensively developed and benchmarked, the next frontier, cell type specific expression (CTSE) deconvolution, remains largely underexplored. Here, we introduce DALE Eval, a comprehensive benchmark of CTSE methods, featuring novel evaluation metrics, identification of key drivers of performance, and practical recommendations for maximizing the value of CTSE in downstream applications.
No takes yet. Share an insight, caveat, or question.
Hu et al. (2025) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: